chevron_leftBack
As of 6 June 2026, S.C. Sintofarm S.A. has a market cap of $5.59M USD, ranking #44019 globally and #145 in Romania.
It ranks #3902 in the Healthcare sector, and #1252 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$5.59MUSD
25.29M RON
Enterprise Value
$5.65MUSD
25.57M RON
Revenue (TTM)
$2.85MUSD
12.88M RON
EBITDA (TTM)
$235.94KUSD
1.07M RON
Net Income (TTM)
$72.25KUSD
327.02K RON
EBITDA Margin
8.3%
Profit Margin
2.5%
PE Ratio
77.3
PS Ratio
2.0
PB Ratio
2.3
EV/EBITDA
23.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
47
Founded
1916
Website
sintofarm.ro
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.8% | -28% | -34% | 55% | 52% | 52% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
SINT
Sintofarm SA Bucuresti
ISIN: ROSINTACNOR6
|
6.55 RON |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About S.C. Sintofarm S.A.
S.C. Sintofarm S.A. manufactures and sells pharmaceutical preparations in Romania. The company offers medicines for human use; medical devices; cosmetic products; biocidal disinfectants; food supplements; and other chemical products. It engages in research and exploitation; and import and export activities. S.C. Sintofarm S.A. was founded in 1916 and is based in Bucharest, Romania.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
BVB: BIO
|
$269.96M
5K%
1.22B RON
|
13.5
|
|
BVB: ATB
|
$264.32M
5K%
1.2B RON
|
23.1
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
14M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
10M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
6M%
|
97.4
|
|
SIX: RO
|
$324.68B
6M%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$289.43B
5M%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$277.35B
5M%
218.9B CHF
|
20.5
|
chevron_leftBack